Bastide Le Confort Medical (LTS:0IP1) Other Stockholders Equity: €-0.0 Mil (As of Dec. 2025)


LTS:0IP1 Bastide Le Confort Medical SA LTS:0IP1
71 GF Score
Price €23.55
GF Value €25.97
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Bastide Le Confort Medical Other Stockholders Equity?

Bastide Le Confort Medical LTS:0IP1 -0.21% 71 Other Stockholders Equity is €-0.0 Mil as of Dec. 2025. GuruFocus rates LTS:0IP1 with a GF Score™ of 71/100 and a GF Value™ of €25.97 (Fairly Valued). The stock has 2 warning signs investors should review.

Bastide Le Confort Medical's Other Stockholders Equity for the quarter that ended in Dec. 2025 was €-0.0 Mil.

Bastide Le Confort Medical's quarterly Other Stockholders Equity declined from Dec. 2024 (€0.0 Mil) to Jun. 2025 (€-0.0 Mil) and declined from Jun. 2025 (€-0.0 Mil) to Dec. 2025 (€-0.0 Mil).

Bastide Le Confort Medical's annual Other Stockholders Equity increased from Jun. 2023 (€-0.0 Mil) to Jun. 2024 (€0.0 Mil) but then declined from Jun. 2024 (€0.0 Mil) to Jun. 2025 (€-0.0 Mil).


Bastide Le Confort Medical Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Bastide Le Confort Medical's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bastide Le Confort Medical Other Stockholders Equity Chart

Bastide Le Confort Medical Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.00 0.00 -0.00 0.00 -0.00

Bastide Le Confort Medical Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.00 0.00 0.00 -0.00 -0.00
LTS:0IP1
71GF Score
Bastide Le Confort Medical SA LTS:0IP1
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bastide Le Confort Medical Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of €-0.0 Mil mean?
Bastide Le Confort Medical (LTS:0IP1) has a Other Stockholders Equity of €-0.0 Mil as of Dec. 2025. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Bastide Le Confort Medical and its competitors.
Is Bastide Le Confort Medical's Other Stockholders Equity too high?
Bastide Le Confort Medical's current Other Stockholders Equity is €-0.0 Mil. Overall, Bastide Le Confort Medical has a GF Score™ of 71/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Bastide Le Confort Medical's Other Stockholders Equity compare to MCK and CAH?
Bastide Le Confort Medical's Other Stockholders Equity of €-0.0 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Medical Distribution company?
A good Other Stockholders Equity depends on the Medical Distribution industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Bastide Le Confort Medical and its competitors. Bastide Le Confort Medical's current Other Stockholders Equity is €-0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bastide Le Confort Medical stock overvalued right now?
Based on GuruFocus' analysis, Bastide Le Confort Medical (LTS:0IP1) is currently considered Fairly Valued. The stock's GF Value™ is €25.97, compared to a current price of €23.55 — trading 9.3% below its estimated fair value. The current Other Stockholders Equity is €-0.0 Mil. Bastide Le Confort Medical's overall GF Score™ is 71/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Bastide Le Confort Medical (LTS:0IP1), the current Other Stockholders Equity is €-0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bastide Le Confort Medical (LTS:0IP1) Overvalued in 2026?

Based on GuruFocus' analysis, Bastide Le Confort Medical stock appears to be undervalued. The current stock price of €23.55 is trading 9.3% below its estimated GF Value™ of €25.97. GuruFocus considers Bastide Le Confort Medical to be Fairly Valued.

Key valuation signals for LTS:0IP1:

  • Other Stockholders Equity: €-0.0 Mil
  • GF Value™: €25.97 vs. price of €23.55 (9.3% below fair value)
  • GF Score™: 71/100 with 2 warning signs

No single metric tells the full story. See the LTS:0IP1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bastide Le Confort Medical Business Description

Other Exchanges BLC:France1DJ:Germany
Address 12, Avenue de la Dame, Caissargues, FRA, 30132
Bastide Le Confort Medical SA is a France-based company that is engaged in the sale and rental of medical supplies and equipment for the home care of the elderly, sick and disabled. The company provides care equipment, such as hospital beds, personal assistance products, nutrition, insulin pumps, and syringe-drivers.
71GF Score

Get the complete analysis for LTS:0IP1

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€23.55
Price
€25.97
GF Value